| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X |
| P698 | PubMed publication ID | 9389558 |
| P2093 | author name string | T G Murray | |
| B R Ksander | |||
| D J Verbik | |||
| J M Tran | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 470-478 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Melanomas that develop within the eye inhibit lymphocyte proliferation | |
| P478 | volume | 73 |
| Q55280433 | A novel combinatorial treatment option for metastatic uveal melanoma. |
| Q39232343 | A role for Jag2 in promoting uveal melanoma dissemination and growth |
| Q90622535 | Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma |
| Q38292114 | Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility. |
| Q64064545 | Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines |
| Q46515186 | Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy! |
| Q35994407 | EMT-associated factors promote invasive properties of uveal melanoma cells |
| Q90611240 | Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma |
| Q74425527 | Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value |
| Q39953555 | Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker |
| Q38699370 | Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines |
| Q30371011 | Growth and Metastasis of Intraocular Tumors in Aged Mice. |
| Q92503867 | HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target |
| Q35233761 | Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation |
| Q37535138 | Immune escape mechanisms of intraocular tumors |
| Q73102575 | Immunology of ocular tumours |
| Q92256945 | Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma |
| Q92946067 | Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a |
| Q34135637 | Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression |
| Q34961980 | Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival |
| Q92273867 | Mouse models of uveal melanoma: Strengths, weaknesses, and future directions |
| Q35794619 | Ocular immune privilege and CTL tolerance |
| Q42200330 | Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? |
| Q45345454 | P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma |
| Q36769330 | PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro |
| Q35006415 | PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells. |
| Q33902364 | PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma. |
| Q99243113 | Quantification of DNA methylation independent of sodium bisulphite conversion using methylation-sensitive restriction enzymes and digital PCR |
| Q93127562 | The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach |
| Q34646857 | Tight Junction–Associated Signaling Pathways Modulate Cell Proliferation in Uveal Melanoma |
| Q36039709 | Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80 |
| Q38724341 | Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). |
| Q39832869 | Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. |
| Q37224538 | Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion |
Search more.